Full name
GENE PLANET POLAND SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
72.11.Z - Scientific research and development activities
46 - Wholesale trade
47 - Retail trade
71 - Architectural and engineering activities, technical testing and analysis
72 - Scientific research and development activities
74 - Other professional, scientific and technical activities
86.90.D - Healthcare
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | -0,2 | 0,4 | -0,6 | -252,2 |
Gross profit (loss) | -0,3 | 0,3 | 0 | -85,3 |
EBITDA | -0,2 | 0,5 | -0,5 | -205,6 |
Short time liabilities | 7,6 | 7,8 | 7,3 | -6,8 |
Other operating costs | 0,1 | 0 | 0 | 18 571 |
Equity capital | -1,3 | -1,1 | -1 | 4,1 |
Operating profit (EBIT) | -0,2 | 0,4 | -0,5 | -226 |
Assets | 6,3 | 6,8 | 6,3 | -7,9 |
Net profit (loss) | -0,3 | 0,3 | 0 | -85,3 |
Cash | 0,4 | 0,5 | 0,7 | 40,6 |
Net income from sale | 5,5 | 7,2 | 6,3 | -11,7 |
Liabilities and provisions for liabilities | 7,7 | 7,8 | 7,3 | -7,2 |
Working assets | 1,2 | 1,7 | 1,4 | -21,9 |
Other income costs | 0 | 0 | 0,1 | 519,1 |
Depreciation | 0,1 | 0,1 | 0 | -84,1 |
% | % | % | p.p. | |
Profitability of capital | 22,2 | -27,7 | -4,2 | 23,5 |
Equity capital to total assets | -21,2 | -15,5 | -16,1 | -0,6 |
Gross profit margin | -5,4 | 4,1 | 0,7 | -3,4 |
EBITDA Margin | -2,7 | 7 | -8,4 | -15,4 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 503 | 396 | 418 | 22 |
Current financial liquidity indicator | 0.15500596165657043 | 0.2229020893573761 | 0.18672528862953186 | 0 |
Net dept to EBITDA | 3.0846426486968994 | -1.0495258569717407 | -4,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane